EPIQ PARTNERS, LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 259 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is 3.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
EPIQ PARTNERS, LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$1,055,194
-25.8%
10,4630.0%0.80%
-17.4%
Q2 2023$1,421,817
+30.8%
10,4630.0%0.96%
+28.7%
Q1 2023$1,086,687
+17.2%
10,4630.0%0.75%
+21.6%
Q4 2022$927,440
+10.5%
10,4630.0%0.62%
+18.9%
Q3 2022$839,000
-16.3%
10,4630.0%0.52%
-15.5%
Q2 2022$1,002,000
-35.5%
10,4630.0%0.61%
-26.6%
Q1 2022$1,554,000
+4.8%
10,4630.0%0.84%
+5.8%
Q4 2021$1,483,000
+8.3%
10,4630.0%0.79%
+25.2%
Q3 2021$1,369,00010,4630.63%
Other shareholders
CONMED CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders